Nura Bio Launches with $73M in Series A Back to HomeSOUTH SAN FRANCISCO, CA, Nura Bio announced its official launch and a $73 million Series A round led by the Column Group.
Nura Bio Inc., a biopharma company created to discover and develop life-changing neuroprotective drugs, today announced its official launch.
Alpna Seth, PhD, a leader in the global biotechnology industry, is President and Chief Executive Officer of Nura Bio.
Prior to joining Nura Bio, Dr. Seth was Chief Operating Officer of Vir Biotechnology.
In addition to Nura Bio, she serves on the boards of Seattle Genetics (NASDAQ:SGEN) and Bio Techne (NASDAQ:TECH).
Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.
About 1% of startups evolve into a unicorn startup, like Uber, Airbnb, Slack, Stripe, and Docker.
Search Startup Around
Boost Your Discovery with Us
Advertise with us to boost your article, content pience, product, event, conference discovery to our readers which includes founders, startup enablers, investors and every key stakeholders from global startup eco-system.